Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturation

Journal of Vascular Surgery

Volumn 54, Issue 2, 2011, Pages 454-460

  Lee, Eugene S ^a   Shen, Qiang ^a   Pitts, Robert L ^a   Guo, Mingzhang ^a   Wu, MacK H ^a   Sun, Sue C ^a   Yuan, Sarah Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; CANNULATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HUMAN; PRIORITY JOURNAL; ULTRACENTRIFUGATION; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; BIOLOGICAL MARKERS; CALIFORNIA; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; UP-REGULATION;

EID: 80955179518     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.02.056     Document Type: Article

References (31)

1. M.T. James, B.J. Manns, B.R. Hemmelgarn, and P. Ravani What's next after fistula first: is an arteriovenous graft or central venous catheter preferable when an arteriovenous fistula is not possible? Semin Dial 22 2009 539 544
2. J.D. Kopple National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure Am J Kidney Dis 37 1 Suppl 2 2001 S137 S181
3. L.M. Dember, G.J. Beck, M. Allon, J.A. Delmez, B.S. Dixon, and A. Greenberg Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial JAMA 299 2008 2164 2171 (Pubitemid 351679707)
4. B.S. Dixon Why don't fistulas mature? Kidney Int 70 2006 1413 1422 (Pubitemid 44527310)
5. M. Tonelli Randomized trials in hemodialysis patients: time to step up to the plate JAMA 299 2008 2205 2207 (Pubitemid 351679714)
6. S.A. Berceli, Z. Jiang, N.V. Klingman, G.S. Schultz, and C.K. Ozaki Early differential MMP-2 and -9 dynamics during flow-induced arterial and vein graft adaptations J Surg Res 134 2006 327 334 (Pubitemid 44092801)
7. C.Y. Chan, Y.S. Chen, M.C. Ma, C.F. Chen, and C.F. Chen Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats J Vasc Surg 45 2007 804 811
8. A.J. Chase, and A.C. Newby Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling J Vasc Res 40 2003 329 343 (Pubitemid 37188102)
9. H. Kargozaran, S.Y. Yuan, J.W. Breslin, K.D. Watson, N. Gaudreault, and A. Breen A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier Clin Exp Metastasis 24 2007 495 502 (Pubitemid 47524807)
10. S. Goodall, M. Crowther, D.M. Hemingway, P.R. Bell, and M.M. Thompson Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms Circulation 104 2001 304 309 (Pubitemid 32666952)
11. E.S. Lee, Q. Shen, R.L. Pitts, M. Guo, M.H. Wu, and S. Yuan Vein tissue expression of matrix metalloproteinase as biomarker for hemodialysis arteriovenous fistula maturation Vasc Endovasc Surg 304 2010 674 679
12. Vascular Access 2006 Work Group Clinical practice guidelines for vascular access Am J Kid Dis 48 Suppl 2006 S176 S247
13. J.D. Raffetto, and R.A. Khalil Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease Biochem Pharmacol 75 2008 346 359 (Pubitemid 350298459)
14. A. Biuckians, E.C. Scott, G.H. Meier, J.M. Panneton, and M.H. Glickman The natural history of autologous fistulas as first-time dialysis access in the KDOQI era J Vasc Surg 47 2008 415 421 discussion: 420-1 (Pubitemid 351172675)
15. S. Misra, A.A. Fu, J.L. Anderson, S. Sethi, J.F. Glockner, and M.A. McKusick The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and -9 at the venous stenosis J Vasc Interv Radiol 19 2008 587 594 (Pubitemid 351423659)
16. M. Wang, D. Zhao, G. Spinetti, J. Zhang, L.Q. Jiang, and G. Pintus Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall Arterioscler Thromb Vasc Biol 26 2006 1503 1509 (Pubitemid 44288975)
17. G.A. Preston, C.V. Barrett, D.A. Alcorta, S.L. Hogan, L. Dinwiddie, and J.C. Jennette Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels Nephron 92 2002 817 823 (Pubitemid 36151362)
18. M. Dobaczewski, C. Gonzalez-Quesada, and N.G. Frangogiannis The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction J Mol Cell Cardiol 48 2010 504 511
19. F. Tronc, Z. Mallat, S. Lehoux, M. Wassef, B. Esposito, and A. Tedgui Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO Arterioscler Thromb Vasc Biol 20 2000 E120 E126
20. J.K. Karwowski, A. Markezich, J. Whitson, T.A. Abbruzzese, C.K. Zarins, and R.L. Dalman Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113;456 J Surg Res 87 1999 122 129 (Pubitemid 29533758)
21. A.M. Tummers, D.J. Mountain, J.W. Mix, S.S. Kirkpatrick, D.C. Cassada, and S.L. Stevens Serum levels of matrix metalloproteinase-2 as a marker of intimal hyperplasia J Surg Res 160 2010 9 13
22. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262 (Pubitemid 34633925)
23. J.S. Alpert, K. Thygesen, E. Antman, and J.P. Bassand Myocardial infarction redefineda consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
24. S. Tsimikas, J.T. Willerson, and P.M. Ridker C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients J Am Coll Cardiol 47 8 Suppl 2006 C19 C31
25. J. Golledge, P.S. Tsao, R.L. Dalman, and P.E. Norman Circulating markers of abdominal aortic aneurysm presence and progression Circulation 118 2008 2382 2392
26. M. Guo, D. Daines, J. Tang, Q. Shen, R.M. Perrin, and Y. Takada Fibrinogen-gamma C-terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism Arterioscler Thromb Vasc Biol 29 2009 394 400
27. Arteriovenous Fistula First http://www.fistulafirst.org Accessed February 21, 2011
28. J. Ethier, D.C. Mendelssohn, S.J. Elder, T. Hasegawa, T. Akizawa, and T. Akiba Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study Nephrol Dial Transplant 23 2008 3219 3226
29. L.M. Spergel Has the Fistula First Breakthrough Initiative caused an increase in catheter prevalence? Semin Dial 21 2008 550 552
30. S.T. Patel, J. Hughes, and J.L. Mills Sr Failure of arteriovenous fistula maturation: an unintended consequence of exceeding dialysis outcome quality initiative guidelines for hemodialysis access J Vasc Surg 38 2003 439 445 discussion:445 (Pubitemid 41123202)
31. C.E. Lok, M. Allon, L. Moist, M.J. Oliver, H. Shah, and D. Zimmerman Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I) J Am Soc Nephrol 17 2006 3204 3212 (Pubitemid 44707782)